FDA issued a final order
Feb. 26 that puts Assisted Reproduction Embryo Image Assessment Systems into class II with special controls.
FDA Inks Class II Designation For Embryo Viability Tests
The agency set a class II with special controls designation for assisted reproduction embryo image assessment systems in a Feb. 26 final order, following the de novo decision for Auxogyn’s Eeva system last summer.